Senate Bill 989 requires health insurers to cover biomarker testing. Dr. Chris Prokash of Texas Oncology says this opens access to more targeted and effective therapies.
Copyright 2023 KERA
© 2024 88.9 KETR
Public Radio for Northeast Texas
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations